Clinical Trial Update: Use of Maytenus Ilicifolia in the Treatment of Dyspepsia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Maytenus Ilicifolia for dyspepsia has been terminated; sponsor is Casa Espirita Terra de Ismael.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Maytenus Ilicifolia (Maytenus ilicifolia)

Snippet

Sponsor: Casa Espirita Terra de Ismael | Conditions: Dyspepsia | Phase 2 | Status: TERMINATED